.5 ml semaglutide 5/0.5 mg/ml WEGOVY 0.5 MG FLEXTOUCH ( ) SOLUTION FOR SUBCUTANEOUS INJECTION PRE-FILLED PEN 5/0.5 mg/ml semaglutide 5/0.5 mg/ml – McKee's proposed FY2027 budget filter:Diabetes-Accessories Specification:40 mg

.5 ml semaglutide 5/0.5 mg/ml WEGOVY 0.5 MG FLEXTOUCH ( ) SOLUTION FOR SUBCUTANEOUS INJECTION PRE-FILLED PEN 5/0.5 mg/ml semaglutide 5/0.5 mg/ml – McKee's proposed FY2027 budget filter:Diabetes-Accessories Specification:40 mg

McKee's proposed FY2027 budget drops GLP-1 drugs for weight loss from Medicaid • Rhode Island Current

While genetics alone does not determine medication efficacy, understanding your predisposition profile can provide valuable context for provider discussions about expected response timelines and dose requirements

filter:Diabetes-Accessories

Specification:40 mg

The proposed mechanisms by which GLP-1 agonists may reduce alcohol consumption involve complex interactions within the brain's reward circuitry